Home | Welcome to Contract Pharma   
Last Updated Sunday, March 29 2015

Print

Topics - Manufacturing


Refine by Date:
From: To:
Published March 27, 2015
Will use RXi's self-delivering RNAi technology to develop cell-based immunotherapies to treat cancer Read More »
Published March 26, 2015
Fully operational to supply comprehensive immunotherapeutic treatments Read More »
Published March 25, 2015
Will receive as much as £652,000 to expand bioproduction research Read More »
Published March 24, 2015
Bangalore oral solids manufacturing facility complied with all FDA requirements Read More »
Published March 23, 2015
To develop targeted anticancer therapeutics for as many as two undisclosed targets Read More »
Published March 20, 2015
$30 million investment in biotechnology will create up to 100 new jobs Read More »
Published March 19, 2015
Will perform tech transfer and support clinical trial for ICT-107 Read More »
Published March 17, 2015
First Taiwanese pharma firm to directly sell generics under its own label in U.S. Read More »
Published March 16, 2015
Manufactures MVA EBOZ for Phase I trial Read More »
Published March 13, 2015
Move will create 100 new jobs, capital investment of more than $9 million Read More »
Published March 12, 2015
Will launch Sofovir in India this month Read More »
Published March 12, 2015
Adds Sensors for Flow Rate Measurement Read More »
Published March 12, 2015
Will provide cGMP manufacture for clinical and commercial supply Read More »
Published March 11, 2015
More than 18,000 sq. ft. of space to be added at Golden West facility Read More »
Published March 9, 2015
Streamlines manufacturing ops into Athlone and Wilmington facilities Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On